Basic Information
ID: ALA5225079
Type: Functional
Description: Antiviral activity against SARS-CoV-2/CANADA/VIDO 01/2020 infected in African green monkey Vero E6 cells assessed as inhibition of plaque formation measured after 48 hrs by crystal violet staining based analysis
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: CANADA/VIDO 01/2020
Cell type: Vero E6
Target: SARS-CoV-2(ALA4303835)
Document: ALA5223130
Antiviral activity against SARS-CoV-2/CANADA/VIDO 01/2020 infected in African green monkey Vero E6 cells assessed as inhibition of plaque formation measured after 48 hrs by crystal violet staining based analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5225079
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 507.54 | 0.54 | 0.54 |
| 403.48 | 1.54 | 1.54 |